{"id":"W2035944548","doi":"10.1016/j.jalz.2006.05.316","title":"O4–03–08: Efficacy and safety of MPC–7869 (R–flurbiprofen), a selective Aβ42–lowering agent, in Alzheimer's disease (AD): Results of a 12–month phase 2 trial and 1–year follow–on study","year":2006,"lang":"en","type":"article","venue":"Alzheimer s & Dementia","topic":"Cholinesterase and Neurodegenerative Diseases","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto; Women's College Hospital","funders":"","keywords":"Medicine; Placebo; Internal medicine; Population; Dosing; Donepezil; Disease; Dementia; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007887787,0.001042219,0.001780219,0.0003141347,0.0003972761,0.0005304521,0.0007050897,0.001499752,0.004589817],"category_scores_gemma":[0.0006206509,0.0003871736,0.0009465795,0.0002456892,0.0005635389,0.0007550713,0.0002151777,0.002045796,0.001427706],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004820603,"about_ca_system_score_gemma":0.0006615934,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001243122,"about_ca_topic_score_gemma":0.001523191,"domain_scores_codex":[0.9997409,0.00007491911,0.00001641586,0.00004241889,0.00003631378,0.0000889404],"domain_scores_gemma":[0.9996315,0.00004409144,0.00007103063,0.00003214905,0.00003836635,0.0001827959],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.763118,0.04298818,0.004890748,0.0005399761,0.0007948034,0.0004914611,0.0001599647,0.000819976,0.05451012,0.0001486059,0.005211228,0.1263268],"study_design_scores_gemma":[0.5510458,0.3986187,0.03686581,0.00004826328,0.0005133087,0.000535702,0.00005921291,0.001387957,0.006235692,0.0001584502,0.004468324,0.00006272887],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9953625,0.001352063,0.0001872053,0.0002454577,0.00006949689,0.000414115,0.0006474921,0.00007434258,0.00164724],"genre_scores_gemma":[0.9929848,0.001149829,0.0005211515,0.0006534975,0.000230656,0.0003850504,0.001634561,0.00002739145,0.002413092],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004589817,"threshold_uncertainty_score":0.01535451,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03776947289243571,"score_gpt":0.3239135375700029,"score_spread":0.2861440646775672,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}